In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved more than 10,000 drug evaluation applications. Almost a quarter of all approvals were given directly without technical reviews. More than 2,100 approvals were granted to Investigational New Drug (IND) applications, while 323 New Drug Applications (NDA) and more than 1,000 Abbreviated New Drug Applications (ANDA) were approved during the year.
Number of drug evaluation applications granted approval in China in 2021, by type of application
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Number of drug evaluation applications granted approval in China in 2021, by type of application
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
National Medical Products Administration. (June 1, 2022). Number of drug evaluation applications granted approval in China in 2021, by type of application [Graph]. In Statista. Retrieved February 20, 2025, from https://www.statista.com/statistics/1319960/china-number-of-drug-evaluation-applications-approved-by-type/
National Medical Products Administration. "Number of drug evaluation applications granted approval in China in 2021, by type of application." Chart. June 1, 2022. Statista. Accessed February 20, 2025. https://www.statista.com/statistics/1319960/china-number-of-drug-evaluation-applications-approved-by-type/
National Medical Products Administration. (2022). Number of drug evaluation applications granted approval in China in 2021, by type of application. Statista. Statista Inc.. Accessed: February 20, 2025. https://www.statista.com/statistics/1319960/china-number-of-drug-evaluation-applications-approved-by-type/
National Medical Products Administration. "Number of Drug Evaluation Applications Granted Approval in China in 2021, by Type of Application." Statista, Statista Inc., 1 Jun 2022, https://www.statista.com/statistics/1319960/china-number-of-drug-evaluation-applications-approved-by-type/
National Medical Products Administration, Number of drug evaluation applications granted approval in China in 2021, by type of application Statista, https://www.statista.com/statistics/1319960/china-number-of-drug-evaluation-applications-approved-by-type/ (last visited February 20, 2025)
Number of drug evaluation applications granted approval in China in 2021, by type of application [Graph], National Medical Products Administration, June 1, 2022. [Online]. Available: https://www.statista.com/statistics/1319960/china-number-of-drug-evaluation-applications-approved-by-type/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.